Redeye: Xavi Solutions - Market challenges remain
Redeye provides a research update on the back of Xavi Solutions’ Q2 2023 report. Net sales came in somewhat below our expectations, mainly stemming from the ongoing market slowdown with lower utilisation rates and increased competition, which made the EBIT lower than anticipated. Overall, we make forecast changes with a subsequent impact on our fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/